Using cannabis therapeutically in the UK: A qualitative analysis

被引:27
作者
Coomber, R [1 ]
Oliver, M
Morris, C
机构
[1] Univ Plymouth, Plymouth PL4 8AA, Devon, England
[2] Univ Greenwich, Sch Social Sci, London SE18 6PF, England
关键词
D O I
10.1177/002204260303300204
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Thirty-three therapeutic cannabis users in England were interviewed about their experiences using an illegal drug for therapeutic purposes. Interviews were semi-structured, and responses highly qualitative. Particular issues included how and why cannabis was used therapeutically; what problems its illegality posed in terms of access, cost, reliability of supply, and quality of the product; the perceived beneficial effects of its use; and unwanted effects (problems in relation to family, friends, partners, the criminal justice system, and the health care system). The study did not seek to prove or disprove the efficacy of cannabis used as a therapeutic agent merely to report the experiences of those who use it in that way. It was found that users perceived cannabis to be highly effective in treating their symptoms, to complement existing medication, and to produce fewer unwanted effects. Smoking was the preferred method of administration, permitting greater control over dose and administration. Problems related to prescribed medication motivated many to use cannabis therapeutically. Few problems were experienced with friends, family, partners, and the criminal justice or health care systems, although other concerns about cannabis's illegality were reported. Although most were relatively unconcerned about the risk involved and were determined to continue use, many resented that they felt they were being forced to break the law. Problems relating to access to the drug (in an illegal context) and managing its administration were reported. A brief discussion of the continued prohibition of cannabis for this group is undertaken, and a harm reduction approach is suggested.
引用
收藏
页码:325 / 356
页数:32
相关论文
共 37 条
[1]  
[Anonymous], 1995, LANCET, V346, P1582
[2]   Biomedical benefits of cannabinoids? [J].
Ashton, CH .
ADDICTION BIOLOGY, 1999, 4 (02) :111-126
[3]   Adverse effects of cannabis and cannabinoids [J].
Ashton, CH .
BRITISH JOURNAL OF ANAESTHESIA, 1999, 83 (04) :637-649
[4]  
BERRIDEGE V, 1999, OPIUM PEOPLE
[5]   SNOWBALL SAMPLING - PROBLEMS AND TECHNIQUES OF CHAIN REFERRAL SAMPLING [J].
BIERNACKI, P ;
WALDORF, D .
SOCIOLOGICAL METHODS & RESEARCH, 1981, 10 (02) :141-163
[6]  
British Medical Association, 1997, THER US CANN
[7]  
CAMPBELL FA, 2001, ARE CANNABINOIDS EFF
[8]  
*CAN SEN SPEC COMM, 2002, CANN OUR POS CAN PUB
[9]  
COLDWELL B, 2001, LANCET, V323, P16
[10]   The adulteration of drugs: What dealers do to illicit drugs, and what they think is done to them [J].
Coomber, R .
ADDICTION RESEARCH, 1997, 5 (04) :297-306